|
Analyses of different parathyroidectomy surgical modalities on the treatment of secondary hyperparathyroidism in uremic patients
2017, 16 (01):
44-47.
doi: 10.3969/j.issn.1671-4091.2017.01.011
Objective To investigate the clinical effects of subtotal parathyroidectomy (S- PTX), total parathyroidectomy (T-PTX), and parathyroidectomy combined with autotransplantation (PTX+AT) on the secondary hyperparathyroidism (SHPT) in uremic patients. Methods A total of 33 SHPT patients treated with SPTX,
T-PTX, or PTX+AT in our hospital during the period April 2014 to April 2015 were retrospectively analyzed. The changes of intact parathyroid hormone (iPTH), serum phosphorus (P), serum calcium (Ca), bone pain and skin itch, and postoperative complications in these patients were studied after the operations. Results ① Surgical operations were successfully performed in all patients. Bone pain, skin itch, and calcification of subcutaneous soft tissue were alleviated with different degrees, with the most effectiveness on bone pain. T-PTX was the most effective modality for relief of SHPT symptoms. ②Serum Ca, P and iPTH reduced significantly after the operation for one week, one month and 6 months in all patients as compared with those before the operation (In T-PTX group, t=3.922, P<0.001 for Ca after one week; t=3.463, P<0.001 for Ca after one month; t=3.114, P=0.006 for Ca after 6 months; t=8.871, P<0.000 for P after one week; t=8.021, P<0.001 for P after one month; t=7.752, P<0.001 for P after 6 months; t=8.175, P<0.001 for iPTH after one week; t=8.175, P<0.001 for iPTH after one month; t =6.817, P<0.001 for iPTH after 6 months. In S-PTX group, t=4.213, P<0.001 for Ca after one week; t=3.277, P=0.0041 for Ca after one month; t=2.816, P=0.021 for Ca after 6 months; t=7.783, P<0.001 for P after one week; t=7.742, P<0.001 for P after one month; t= 7.742, P<0.001 for P after 6 months; t=5.933, P<0.001 for iPTH after one week; t=4.875, P<0.001 for iPTH after one month; t=4.886, P<0.001 for iPTH after 6 months. In PTX+AT group, t=3.114, P=0.006 for Ca after one week; t=3.206, P=0.005 for Ca after one month; t=4.027, P<0.001 for Ca after 6 months; t= 8.922, P<0.001 for P after one week; t=7.811, P<0.001 for P after one month; t=7.774, P<0.001 for P after 6 months; t=7.947, P<0.001 for iPTH after one week; t=7.335. P<0.001 for iPTH after one month; t=7.220, P<0.001 for iPTH after 6 months). Serum Ca and P after the operation for one week, one month and 6 months had no statistical significances among the 3 groups (F=2.498, P=0.074 for Ca after one week; F= 3.080, P=0.065 for Ca after one month; F=2.771, P=0.069 for Ca after 6 months; F=1.094, P=0.195 for P after one week; F=1.933, P=0.178 for P after one month; F=2.011, P=0.169 for P after 6 months). Serum iPTH levels were statistically higher in S-PTX group than in T-PTX group (t=6.855, P=0.006 after one week; t= 7.288, P=0.003 after one month, t=6.732, P=0.006 after 6 months). Serum iPTH levels had no differences after the operation for one week between PTX+AT group and T-PTX group (t=2.317, P=0.083), but were higher after the operation for one month and 6 months in PTX+AT group than in T-PTX group (t=6.609, P=0.008 after one month; t=5.985, P=0.011 after 6 months). ③No obvious complications were found after the operations. Conclusion The operations of T-PTX, S-PTX and PTX+AT are safe and can all treat uremia SHPT effectively. The reduction of serum Ca and P showed no difference among the 3 groups, but the reduction of iPTH was most effectively in T-PTX group.
Metrics
|